文献速递脑血管病

蛋白质组学与缺血性卒中发病风险:ARIC研究与CHS研究的荟萃分析

Proteomics and Risk of Incident Ischemic Stroke: Meta-Analysis of the ARIC Study and CHS
RSS 订阅 · Stroke

在ARIC与CHS两个队列中检测4954种血浆蛋白,中位随访25年和12年,14139名参与者中1397人发生缺血性卒中。发现44种蛋白与缺血性卒中风险显著相关,其中26种为新发现;孟德尔随机化提示MMP12和CNTN1可能与缺血性卒中风险存在因果关联。

要点

  • 44种蛋白与缺血性卒中风险显著相关(P<1.0×10−5),其中26种为新发现。
  • 在两个独立队列中,37种(84%)关联方向一致,26种(59%)达到复制标准。
  • 孟德尔随机化提示MMP12水平升高对缺血性卒中风险有直接保护作用,CNTN1有直接危害作用。

核心结论

  • 该蛋白质组与基因组研究识别了缺血性卒中的新风险生物标志物及2种潜在病因性CNTN1因子,后者受动脉粥样硬化和肥胖调控。
  • 若未来研究证实上述发现,这些结果可能对开发新的预防性治疗有启示。

研究设计与样本

  • 纳入ARIC研究(1990—1992年)和CHS研究(1992—1993年)中蛋白质组检测时无卒中史的参与者。
  • 采用适配体检测血液蛋白相对浓度(n=4954),ARIC随访至2019年、CHS随访至2015年判定缺血性卒中事件。
  • 采用研究特异性Cox回归校正缺血性卒中危险因素,固定效应荟萃分析合并研究特异性估计值,并在AGES-Reykjavik和UK Biobank两个独立队列中复制。
  • 以错误发现率q值<0.05作为复制标准,并行孟德尔随机化分析评估蛋白与缺血性卒中的潜在因果关联。

主要发现

  • ARIC和CHS中位随访分别为25年和12年,14139名参与者中1397人(10%)发生缺血性卒中。
  • 44种蛋白与缺血性卒中风险显著相关(P<1.0×10−5),其中26种为新发现。
  • 在两个独立队列中,37种(84%)关联方向一致,26种(59%)达到复制标准。
  • 孟德尔随机化分析提示MMP12(基质金属蛋白酶-12)和CNTN1(接触蛋白-1)可能与缺血性卒中风险存在因果关联。
  • 多变量孟德尔随机化分析中,MMP12水平较高对缺血性卒中风险有直接保护作用,而CNTN1有直接危害作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. BACKGROUND:Ischemic stroke preventive therapies have been slow to emerge due to a limited understanding of the underlying molecular mechanisms. We aimed to discover new protein risk factors that are potential etiologic factors and may be candidates for therapeutic intervention.METHODS:We included ARIC study (Atherosclerosis Risk in Communities) and CHS (Cardiovascular Health Study) participants without prevalent stroke at the time of proteomic profiling (1990–1992 in ARIC and 1992–1993 in CHS). Relative concentrations of proteins in blood were assessed with aptamers (n=4954). Ischemic stroke events were adjudicated through 2019 in ARIC and 2015 in CHS. Study-specific Cox regression adjusting for ischemic stroke risk factors was used to estimate associations between proteins and incident ischemic stroke. Study-specific estimates were combined using fixed-effects meta-analysis. Replication was conducted in 2 independent cohorts (AGES-Reykjavik, UK Biobank). Proteins with a false discovery rateqvalue <0.05 were considered replicated. Mendelian randomization analyses assessed for potential causal associations between proteins and ischemic stroke.RESULTS:Median follow-up was 25 and 12 years in ARIC and CHS. 1397 out of 14 139 (10%) participants experienced an ischemic stroke. 44 proteins were significantly associated with ischemic stroke risk (P<1.0×10−5), of which 26 are novel. In 2 independent cohorts, 37 (84%) associations were directionally concordant, and 26 (59%) met criteria for replication. Mendelian randomization analyses suggested MMP12 (matrix metallopeptidase-12) and CNTN1 (contactin-1) may be causally related to ischemic stroke risk. In multivariable Mendelian randomization analyses, higher MMP12 levels had a direct protective effect on ischemic stroke risk, while CNTN1 had a direct harmful effect.CONCLUSIONS:This proteomic and genomic investigation of ischemic stroke identified novel risk biomarkers and 2 potential etiologic CNTN1 factors that are regulated in response to atherosclerosis and obesity. If future studies confirm our findings, these results may have implications for the development of new preventive therapies.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Proteomics and Risk of Incident Ischemic Stroke: Meta-Analysis of the ARIC Study and CHS

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。